Logos Global Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-650,000	Closed	-$9.16M	–	39
2022 Q2	$9.16M	Buy	+650,000	New	+$9.16M	1.68%	18